Kinsale Capital Group Valuation
Is KNSL undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
1/6Valuation Score 1/6
Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of KNSL when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: KNSL ($489.92) is trading below our estimate of fair value ($572.28)
Significantly Below Fair Value: KNSL is trading below fair value, but not by a significant amount.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for KNSL?
Key metric: As KNSL is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.
| What is KNSL's PE Ratio? | |
|---|---|
| PE Ratio | 27.9x |
| Earnings | US$409.14m |
| Market Cap | US$11.14b |
| Key Statistics | |
|---|---|
| Enterprise Value/Revenue | 7.3x |
| Enterprise Value/EBITDA | 21.6x |
| PEG Ratio | 3.3x |
Price to Earnings Ratio vs Peers
How does KNSL's PE Ratio compare to its peers?
| Company | Forward PE | Estimated Growth | Market Cap |
|---|---|---|---|
| Peer Average | 14.6x | ||
AIZ Assurant | 15.3x | 14.5% | US$11.2b |
AFG American Financial Group | 13.5x | 8.6% | US$11.8b |
RLI RLI | 19.4x | -10.9% | US$8.1b |
CNA CNA Financial | 10.2x | 15.9% | US$13.2b |
KNSL Kinsale Capital Group | 27.9x | 8.4% | US$11.1b |
Price-To-Earnings vs Peers: KNSL is expensive based on its Price-To-Earnings Ratio (27.9x) compared to the peer average (14.7x).
Price to Earnings Ratio vs Industry
How does KNSL's PE Ratio compare vs other companies in the US Insurance Industry?
Price-To-Earnings vs Industry: KNSL is expensive based on its Price-To-Earnings Ratio (27.9x) compared to the US Insurance industry average (13.5x).
Price to Earnings Ratio vs Fair Ratio
What is KNSL's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
| Fair Ratio | |
|---|---|
| Current PE Ratio | 27.9x |
| Fair PE Ratio | 11.7x |
Price-To-Earnings vs Fair Ratio: KNSL is expensive based on its Price-To-Earnings Ratio (27.9x) compared to the estimated Fair Price-To-Earnings Ratio (11.7x).
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
| Date | Share Price | Average 1Y Price Target | Dispersion | High | Low | 1Y Actual price | Analysts |
|---|---|---|---|---|---|---|---|
| Current | US$489.92 | US$465.88 -4.9% | 8.1% | US$535.00 | US$415.00 | n/a | 8 |
| Nov ’25 | US$426.03 | US$463.88 +8.9% | 8.3% | US$535.00 | US$415.00 | n/a | 8 |
| Oct ’25 | US$476.24 | US$446.14 -6.3% | 8.5% | US$530.00 | US$403.00 | n/a | 7 |
| Sep ’25 | US$491.09 | US$449.00 -8.6% | 7.5% | US$514.00 | US$403.00 | n/a | 8 |
| Aug ’25 | US$447.33 | US$448.25 +0.2% | 7.6% | US$514.00 | US$403.00 | n/a | 8 |
| Jul ’25 | US$391.71 | US$418.38 +6.8% | 4.8% | US$453.00 | US$390.00 | n/a | 8 |
| Jun ’25 | US$383.62 | US$419.63 +9.4% | 4.7% | US$453.00 | US$390.00 | n/a | 8 |
| May ’25 | US$378.61 | US$422.00 +11.5% | 4.8% | US$453.00 | US$390.00 | n/a | 7 |
| Apr ’25 | US$512.65 | US$530.86 +3.6% | 11.5% | US$607.00 | US$420.00 | n/a | 7 |
| Mar ’25 | US$517.28 | US$530.86 +2.6% | 11.5% | US$607.00 | US$420.00 | n/a | 7 |
| Feb ’25 | US$394.27 | US$410.00 +4.0% | 8.0% | US$451.00 | US$370.00 | n/a | 7 |
| Jan ’25 | US$334.91 | US$410.00 +22.4% | 8.0% | US$451.00 | US$370.00 | n/a | 7 |
| Dec ’24 | US$338.48 | US$412.14 +21.8% | 7.6% | US$451.00 | US$370.00 | n/a | 7 |
| Nov ’24 | US$343.15 | US$412.14 +20.1% | 7.6% | US$451.00 | US$370.00 | US$426.03 | 7 |
| Oct ’24 | US$414.13 | US$428.71 +3.5% | 11.7% | US$521.00 | US$350.00 | US$476.24 | 7 |
| Sep ’24 | US$402.93 | US$398.33 -1.1% | 9.3% | US$450.00 | US$350.00 | US$491.09 | 6 |
| Aug ’24 | US$373.50 | US$398.33 +6.6% | 9.3% | US$450.00 | US$350.00 | US$447.33 | 6 |
| Jul ’24 | US$374.20 | US$356.00 -4.9% | 9.9% | US$400.00 | US$300.00 | US$391.71 | 6 |
| Jun ’24 | US$312.48 | US$336.17 +7.6% | 12.9% | US$400.00 | US$270.00 | US$383.62 | 6 |
| May ’24 | US$327.42 | US$332.00 +1.4% | 15.2% | US$400.00 | US$245.00 | US$378.61 | 6 |
| Apr ’24 | US$300.15 | US$323.83 +7.9% | 16.8% | US$400.00 | US$230.00 | US$512.65 | 6 |
| Mar ’24 | US$317.40 | US$323.83 +2.0% | 16.8% | US$400.00 | US$230.00 | US$517.28 | 6 |
| Feb ’24 | US$282.41 | US$299.00 +5.9% | 14.2% | US$350.00 | US$230.00 | US$394.27 | 6 |
| Jan ’24 | US$261.52 | US$312.00 +19.3% | 11.5% | US$350.00 | US$250.00 | US$334.91 | 5 |
| Dec ’23 | US$301.86 | US$317.50 +5.2% | 12.4% | US$350.00 | US$250.00 | US$338.48 | 4 |
| Nov ’23 | US$323.03 | US$317.50 -1.7% | 12.4% | US$350.00 | US$250.00 | US$343.15 | 4 |
Analyst Forecast: Target price is lower than the current share price.
Discover undervalued companies
Fidelis Insurance Holdings
US$2.2b
A specialty insurer, provides insurance and reinsurance solutions in Bermuda, the Republic of Ireland, and the United Kingdom.
FIHL
US$19.90
7D
-0.2%
1Y
62.1%
Markel Group
US$21.5b
A diverse holding company, engages in marketing and underwriting specialty insurance products in the United States, Bermuda, the United Kingdom, and Germany.
MKL
US$1,694.12
7D
2.3%
1Y
18.5%
China Life Insurance
HK$1.1t
Operates as a life insurance company in the People’s Republic of China.
CILJ.F
HK$2.00
7D
-0.6%
1Y
46.0%